101969-4 |
Facial expression |
Find |
Face |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Facial expression |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
101969-4 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Face Express |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.78 |
2.75 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
10197-2 |
Physical findings |
Find |
Eye |
Pt |
Nar |
Observed |
|
ACTIVE |
Physical findings of Eye Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
10197-2 |
|
Observed |
|
|
|
|
|
|
0 |
Phys find Eye |
|
|
|
|
|
Exam; Examination; Eyeball; Finding; Findings; H+P; H+P.PX; Narrative; Occular; Oculis; Ophthalmologic; Optic globe; P prime; Phys find; Point in time; Random; Report; Vision; Visual |
2.4 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
101970-2 |
Breathing patterns |
Find |
Respiratory |
Pt |
Ord |
|
|
ACTIVE |
Breathing patterns |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
101970-2 |
|
|
|
|
Observation |
|
|
|
0 |
Breath pat |
|
|
|
N |
|
Breath Pat; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; PAINAD.breathing; Point in time; QL; Qual; Qualitative; Random; Screen |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101971-0 |
Cry |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Cry |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
101971-0 |
|
|
|
|
Observation |
|
|
|
0 |
Cry |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101972-8 |
State of arousal |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
State of arousal |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
101972-8 |
|
|
|
|
Observation |
|
|
|
0 |
State of arousal |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.76 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101973-6 |
Total score (0 to 7) |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Total score (0 to 7) |
|
MAJ |
DefinitionDescription |
|
|
|
|
�© 1989, Children's Hospital of Eastern Ontario. Used with permission. |
|
|
|
|
H&P.HX |
|
101973-6 |
|
|
|
|
Observation |
|
|
|
0 |
Total score (0 to 7) |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Tot; Totl |
2.76 |
2.75 |
|
|
|
|
�© 1989, Children's Hospital of Eastern Ontario. Used with permission. |
|
|
|
|
|
|
0 |
101974-4 |
Arms |
Find |
^Patient |
Pt |
Ord |
NIPS |
|
ACTIVE |
Arms |
|
MAJ |
DefinitionDescription |
|
|
|
|
�© 1989, Children's Hospital of Eastern Ontario. Used with permission. |
|
|
|
|
H&P.HX |
|
101974-4 |
|
NIPS |
|
|
Observation |
|
|
|
0 |
Arms |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.76 |
2.75 |
|
|
|
|
�© 1989, Children's Hospital of Eastern Ontario. Used with permission. |
|
|
|
|
|
|
0 |
101975-1 |
Legs |
Find |
^Patient |
Pt |
Ord |
NIPS |
|
ACTIVE |
Legs |
|
MAJ |
DefinitionDescription |
|
|
|
|
�© 1989, Children's Hospital of Eastern Ontario. Used with permission. |
|
|
|
|
H&P.HX |
|
101975-1 |
|
NIPS |
|
|
Observation |
|
|
|
0 |
Legs |
|
|
|
N |
|
Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen |
2.76 |
2.75 |
|
|
|
|
�© 1989, Children's Hospital of Eastern Ontario. Used with permission. |
|
|
|
|
|
|
0 |
101976-9 |
Voltage-gated calcium channel PQ type binding Ab |
MCnc |
Ser |
Pt |
Qn |
IA |
|
ACTIVE |
Voltage-gated calcium channel P/Q type binding Ab [Mass/volume] in Serum by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
g/dL |
|
|
|
|
|
|
SERO |
|
101976-9 |
|
IA |
|
|
Both |
|
|
|
0 |
VGCC-P/Q Bind Ab Ser IA-mCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bind; Ca; Cal; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Lamblia intestinalis; LEMS; Level; Mass concentration; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS; VDCC; VG; V-G; VGCC; VGCC-P/Q Bind; Voltage-dependent calcium channels |
2.75 |
2.75 |
|
|
|
|
|
|
|
g/dL |
|
|
|
0 |
101977-7 |
Cortisol, glucose and somatotropin post glucagon stimulation panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Cortisol, glucose and somatotropin post glucagon stimulation panel - Serum or Plasma |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
101977-7 |
|
|
|
|
Order |
|
|
|
0 |
Cort+gluc+som p gluca pnl SerPl |
|
|
|
N |
|
17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cort+gluc+som p gluca pnl; F; GH; Glu; Glu tol; Gluc; Gluc+soma p gluca pnl; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGF; HGH; Human growth hormone; hydrocortisone; Hyperglycemic factor; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH; Stim |
2.77 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
101978-5 |
Glucose and somatotropin post glucagon stimulation panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Glucose and somatotropin post glucagon stimulation panel - Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
101978-5 |
|
|
|
|
Order |
|
|
|
0 |
Gluc+soma p gluca pnl SerPl |
|
|
|
N |
|
After; CHEMISTRY.CHALLENGE TESTING; GH; Glu; Glu tol; Gluc; Gluc+soma p gluca pnl; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGF; HGH; Human growth hormone; Hyperglycemic factor; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH; Stim |
2.76 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
101979-3 |
Cortisol post arginine stimulation panel |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Cortisol post arginine stimulation panel - Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
101979-3 |
|
|
|
|
Order |
|
|
|
0 |
Cortsol p argi pnl SerPl |
|
|
|
N |
|
17-Hydroxycorticosterone; After; Arg; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Cortsol p argi pnl; F; hydrocortisone; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stim |
2.76 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
10198-0 |
Physical findings |
Find |
Genitourinary tract |
Pt |
Nar |
Observed |
|
ACTIVE |
Physical findings of Genitourinary tract Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
10198-0 |
|
Observed |
|
|
|
|
|
|
0 |
Phys find GU Tract |
|
|
|
|
|
Exam; Examination; Finding; Findings; GU Tract; H+P; H+P.PX; Narrative; P prime; Phys find; Point in time; Random; Report |
2.4 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
101980-1 |
Glucose, somatotropin and cortisol post insulin administration |
- |
Ser/Plas |
Pt |
- |
|
|
ACTIVE |
Glucose, somatotropin and cortisol post insulin administration in Serum or Plasma |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHAL |
|
101980-1 |
|
|
|
|
Order |
|
|
|
0 |
Gluc+som+cort p insu pnl SerPl |
|
|
|
N |
|
17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; GH; Glu; Glu tol; Gluc; Gluc+som+cort p insu pnl; Glucose tolerance; Glucoseur; Growth hormone; GTT; HGH; HUM; Human growth hormone; Humulin; hydrocortisone; IH7; Insul; Lente; NPH; Pan; Panel; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; Somatotropic hormone; SR; STH; Ultralente |
2.76 |
2.75 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
101981-9 |
Maximum clot strength amplitude.kaolin induced |
Len |
Bld |
Pt |
Qn |
Thromboelastography.resonance |
|
ACTIVE |
Maximum amplitude kaolin induced [Length] in Blood by Resonance TEG |
|
ADD |
DefinitionDescription |
|
|
mm |
|
|
|
|
|
|
COAG |
|
101981-9 |
|
Thromboelastography.resonance |
|
|
Both |
|
|
|
0 |
MA kaolin Bld Res TEG |
|
|
|
N |
|
Blood; COAGULATION; HKH MA; HKHMA; Length; MA kaolin; MA, HKH; MAK; MAthrombin; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood |
2.75 |
2.75 |
|
|
|
|
|
|
|
mm |
|
|
|
0 |
101982-7 |
Respiratory syncytial virus A B |
PrThr |
Respiratory System Specimen |
Pt |
Ord |
Probe.amp.tar |
|
DEPRECATED |
Deprecated Respiratory syncytial virus A B [Presence] in Respiratory system specimen by NAA with probe detection |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101982-7 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Deprecated RSV A B RNA Resp Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Amplif; Amplification; Amplified; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; RSV; RSV A; RSV A B RNA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.76 |
2.75 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
101983-5 |
Influenza virus A+B RNA |
PrThr |
Respiratory System Specimen |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Influenza virus A+B RNA [Presence] in Respiratory system specimen by NAA with probe detection |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101983-5 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUAV+FLUBV RNA Resp Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Breathing; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV + FLUBV; FLUAV+FLUBV; FLUV; Fowl plague; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101984-3 |
Candida albicans DNA |
PrThr |
Body fld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida albicans DNA [Presence] in Body fluid by Probe.amp.tar |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101984-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C albicans DNA Fld Ql Probe.amp.tar |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C albicans; C albicans DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fl; Fld; FLU; Fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; m005; m5; Microbiology; Monilia; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Thrush; TMA; Transcription mediated amplification |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101985-0 |
Candida parapsilosis DNA |
PrThr |
Body fld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida parapsilosis DNA [Presence] in Body fluid by Probe.amp.tar |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101985-0 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C parap DNA Fld Ql Probe.amp.tar |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C parap; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fl; Fld; FLU; Fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101986-8 |
Candida krusei DNA |
PrThr |
Body fld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida krusei DNA [Presence] in Body fluid by Probe.amp.tar |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101986-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C krusei DNA Fld Ql Probe.amp.tar |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C krusei; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fl; Fld; FLU; Fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101987-6 |
Candida glabrata DNA |
PrThr |
Body fld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida glabrata DNA [Presence] in Body fluid by Probe.amp.tar |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101987-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C glabrata DNA Fld Ql Probe.amp.tar |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C glabrata; C glabrata DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fl; Fld; FLU; Fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Torulopsis glabrata; Transcription mediated amplification |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101988-4 |
Candida tropicalis DNA |
PrThr |
Body fld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida tropicalis DNA [Presence] in Body fluid by Probe.amp.tar |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101988-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C tropicls DNA Fld Ql Probe.amp.tar |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C tropicls; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fl; Fld; FLU; Fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
101989-2 |
Candida dubliniensis DNA |
PrThr |
Body fld |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Candida dubliniensis DNA [Presence] in Body fluid by Probe.amp.tar |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
101989-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
C dubliniensis DNA Fld Ql Probe.amp.tar |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C dubliniensis; C. dubliniensis DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Fl; Fld; FLU; Fluid; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.75 |
2.75 |
|
|
|
|
|
|
|
|
|
|
|
0 |
10199-8 |
Physical findings |
Find |
Head |
Pt |
Nar |
Observed |
|
ACTIVE |
Physical findings of Head Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.PX |
|
10199-8 |
|
Observed |
|
|
|
|
|
|
0 |
Phys find Head |
|
|
|
|
|
Brain; Cranial; Cranium; Exam; Examination; Finding; Findings; H+P; H+P.PX; Intracranial; Narrative; P prime; Phys find; Point in time; Random; Report; Skull |
2.4 |
1.0i |
|
|
|
|
|
|
|
|
|
|
|
0 |
101990-0 |
Xanthurenate |
MRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Xanthurenate [Mass Ratio] in Urine |
|
ADD |
DefinitionDescription |
|
|
ug/g creatinine |
|
|
|
|
|
|
CHEM |
|
101990-0 |
|
|
|
|
Both |
|
|
|
0 |
Xanthuren Ur |
|
|
|
N |
|
Chemistry; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; XA; Xanthurenic acid |
2.75 |
2.75 |
|
|
|
|
|
|
|
ug/g{creat} |
|
|
|
0 |